ArticleEuropean urology2016

Re: Addition of Docetaxel, Zoledronic Acid, or Both to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial.

Cora N SternbergPubMed ↗Publisher ↗

No numbers read from the abstract.